Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $3.48 | Prev. Close $3.55 | Circuit Range N/A |
Day Range $3.48 - $3.48 | Year Range $3.18 - $25.00 | Volume 299 |
Average Traded $3.48 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
24-Dec-25 | $3.48 | $3.48 | +0.00% |
24-Dec-25 | $3.48 | $3.48 | -1.97% |
23-Dec-25 | $3.55 | $3.55 | +2.16% |
18-Dec-25 | $3.52 | $3.48 | -0.43% |
17-Dec-25 | $3.66 | $3.49 | -2.24% |
16-Dec-25 | $3.58 | $3.57 | -4.80% |
15-Dec-25 | $3.83 | $3.75 | -8.87% |